| Developers: | Abbott Laboratories |
| Date of the premiere of the system: | November, 2020. |
| Branches: | Pharmaceutics, medicine, health care |
2020: The announcement of IonicRF - the device for radio-frequency ablation
In the middle of November, 2020 Abbott released the device for radio-frequency ablation of IonicRF for non-invasive treatment of the pain syndrome connected with damage of nervous system. This device provides minimum invasive treatment by means of radio-frequency ablation. Heat caused by waves influences certain nerves and blocks signals of pain receptors before those reach back and a brain. According to the press release, this first device for radio-frequency ablation developed by Abbott and which got approval of regulatory bodies in the USA and Europe.
Doctor Jason Pope from the center of recovery Evolve in Santa-Rose (California) noted that Abbott IonicRF has several "promising aspects", for example, can help doctors at fight against pains with several certain areas of a body. Researches showed that pain relief after the single procedure of radio-frequency ablation can last from six to 12 months. Radio-frequency ablation was used for treatment of pain of different genesis, including waist pain and sacral podvzdoshnom a joint. At the same time radio-frequency ablation allowed to relieve pain which did not answer conservative methods of therapy, such as physical therapy, the injection and tableted medicines.
| Most of patients who are considered as candidates for radio-frequency ablation other methods of treatment already tested, but did not achieve significant success, - noted the vice president of Abbott for development of devices of neuromodulation Keith Boettiger. - As a result they look for the alternative solution which does not require surgical intervention or use of opioid medicines. We are proud that we can provide the first device for radio-frequency ablation developed by Abbott which provides safe and effective anesthesia.[1] |

